• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Johnson & Johnson

    < Previous 1 2 3 Next >
    Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson Reports Q3 2024 Results
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Participate in the Stifel 2024 Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson Completes Acquisition of V-Wave
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson Announces that its Subsidiary, Red River Talc LLC, has Filed a Voluntary Prepackaged Chapter 11 Case to Resolve All Current and Future Ovarian Cancer Talc Claims
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson’s Executive Vice President, Chief Human Resources Officer Peter Fasolo to Retire; Kristen Mulholland Named Chief Human Resources Officer, Effective October 1, 2024
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Acquire V-Wave
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson reports Q2 2024 results
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson Completes Acquisition of Proteologix, Inc.
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson Completes Acquisition of Shockwave Medical
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Acquire Shockwave Medical
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ SWAV
    Johnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson Expands Commitment to Advance Health Equity
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson to Participate in the BofA Securities Health Care Conference
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
    From Johnson & Johnson
    Via Business Wire
    Tickers JNJ
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.